UPDATE 1-Gilead combo HIV pill matches Truvada efficacy but safer in trial

Sept 2 (Reuters) - Gilead Sciences Inc said on Wednesday its experimental fixed-dose combination treatment for HIV proved as effective in a late-stage study as the company's widely used Truvada combo pill but with significantly less loss of bone mineral density and kidney function.